# Kinetics — Vision

> 100-domain scope register: docs/SCIENCE_DOMAIN_CATALOGUE_100.md. This catalogue defines intended breadth; it is not evidence that every domain is implemented or clinically validated.
## North star

The authoritative, expanded project mission is maintained in [KINETICS_MISSION.md](KINETICS_MISSION.md). It governs the long-horizon goal: a globally useful, cross-disciplinary biomedical and precision-health research infrastructure that connects scientific evidence to better prevention and treatment research, without claiming clinical validity before it is demonstrated.

Build a unified biomedical research environment in which scientists can connect molecular mechanisms to disease biology, therapeutic discovery and, through years of rigorous validation, research that may improve future treatment.

Kinetics should make fragmented evidence computationally connected, experimentally traceable and reproducible. It should help researchers ask better questions, generate testable hypotheses, compare explanations, design experiments and understand where knowledge is uncertain.

The ambition is exceptionally large; claims must remain proportional to evidence. Kinetics is not currently a clinical system and will not autonomously diagnose, prescribe or direct treatment.

## The future scientific platform

### 1. Biological knowledge foundation
Create a provenance-aware, versioned knowledge layer connecting genes, variants, transcripts, proteins, structures, compounds, reactions, pathways, phenotypes, diseases, assays, samples, cohorts, publications and clinical evidence. Every relationship must retain source, context, evidence type, confidence and version. Preserve conflicts and missingness rather than silently resolving them.

### 2. Genomics and molecular genetics
Support reference-aware sequence workflows, variant normalization and annotation, gene regulation, transcript structure, splicing, rare-variant research, population frequencies and pharmacogenomic evidence. Clearly communicate reference build, transcript choice, ancestry limitations and uncertainty.

### 3. Transcriptomics and cellular biology
Integrate bulk, single-cell and spatial transcriptomics; expression, differential expression, regulatory networks, cell states and perturbation datasets. Track sample, tissue, timepoint, batch, platform and cohort context.

### 4. Proteomics and structural biology
Study protein sequence, domains, conservation, folding, stability, structure, complexes, interfaces, mutations and interactions. Distinguish experimental structures from predicted models and record quality/confidence.

### 5. Enzyme kinetics and biochemical systems
Expand the existing Km/kcat foundation into assay-aware biochemical research, reaction networks, catalytic mechanisms, cofactors, pH/temperature effects, enzyme engineering and experimentally grounded prediction.

### 6. Chemistry and therapeutic discovery
Build compound identity and reaction services, molecular descriptors, target–ligand evidence, virtual screening, docking, ADMET/toxicity research, selectivity and lead optimization. Every candidate score must show its evidence, applicability domain and uncertainty.

### 7. Molecular simulation and physical modelling
Support validated molecular preparation, molecular dynamics, conformational ensembles, binding-site dynamics and selected free-energy methods. Preserve force-field, parameter, sampling and software provenance. Simulations are not experimental observations.

### 8. Disease and systems biology
Connect molecular perturbations to pathways, cell states, tissue context and disease phenotypes. Support networks, perturbation analysis and causal hypotheses with explicit assumptions and sensitivity analysis. Correlation must not be presented as causation.

### 9. Multi-omics and biological individuality
Integrate genomic, epigenomic, transcriptomic, proteomic, metabolomic, lipidomic, microbiome, imaging and longitudinal evidence. Study response heterogeneity without assuming that genes alone determine health or treatment outcomes. Evaluate population coverage and subgroup performance.

### 10. Biomedical imaging and spatial intelligence
Support DICOM, NIfTI, microscopy and appropriate scientific formats; 2D/3D/4D viewing; volume rendering; segmentation; registration; quantitative measurements; annotations; spatial overlays and multimodal alignment. Preserve geometry, units, metadata and source images. Validate algorithms against expert-annotated benchmarks.

### 11. Pharmacology and treatment-response research
Study target engagement, pharmacokinetics/pharmacodynamics, exposure–response, drug–gene and drug–drug evidence, toxicity and treatment-effect heterogeneity. Integrate clinical context only under appropriate consent, governance and validation. No genotype or model score alone determines a treatment.

### 12. Experimental and translational research
Support study design, protocol tracking, cohort criteria, power planning, assay QC, replicate handling, negative-result capture, external validation and publication-ready reproducibility packages.

### 13. Kinetics Ecosystem AI
A separate, independently developed project will become the research companion through versioned APIs. It may retrieve literature, explain workflows, query approved project data, plan analyses and orchestrate permission-scoped tools. It must cite sources, label uncertainty, request approval for consequential actions and never become an autonomous clinical decision-maker. It is not Astronaut.

## Engineering vision

- **Python:** scientific computing, bioinformatics, cheminformatics, machine learning, data ingestion, workflow orchestration, APIs and reporting.
- **C++:** native 3D scene engine, rendering, GPU resources, molecular and volumetric visualization, geometry and high-performance image processing.
- **Rust:** secure project/file services, concurrency, job lifecycle, integrity checks, resource limits and selected portable components.
- **Interoperability:** versioned schemas, narrow APIs, explicit ownership and tested language bindings.
- **Foundation first:** complete the scientific data, knowledge, analysis, security and API foundations before polished end-user applications.
- **Desktop and Android clients:** build both against stable contracts; low-memory Android devices are a first-class performance target from the start. Large training, image volumes and simulations remain on suitable compute.

## Future treatment impact

The ultimate aspiration is to help the scientific and medical communities understand why disease and treatment response differ, discover better therapeutic candidates, identify validated biomarkers and evaluate more precise interventions. A future clinical workflow may support qualified professionals only for a specific, validated and authorized purpose.

Progression to patient care requires independent prospective clinical evidence, ethics review, qualified partners, quality management, risk management, cybersecurity, usability assessment and jurisdiction-specific regulatory authorization. Research success does not automatically establish clinical utility.

## Non-negotiable principles

1. Evidence before claims.
2. Provenance for every dataset, transformation, model and result.
3. Raw measurements, normalized data, simulations and predictions remain distinct.
4. Reproducible workflows and versioned artifacts.
5. Leakage-resistant evaluation and independent validation.
6. Visible uncertainty, out-of-domain warnings and known failure modes.
7. Privacy, consent, security and equitable performance by design.
8. Human oversight for high-impact interpretation.
9. Modular, interoperable, maintainable engineering.
10. Clinical deployment is a separate gated programme.

## A picture of success

A researcher investigates a disease mechanism, traces variants to genes and proteins, inspects structures and interactions, studies kinetic and chemical evidence, integrates omics and imaging, compares therapeutic hypotheses, designs an experiment and produces a reproducible report in one coherent environment.

Over years, validated components may contribute to better translational research and, where evidence and authorization permit, carefully scoped clinical tools. Kinetics should become infrastructure for better biomedical questions—and help make better treatment research possible.


## Offline resilience and humanitarian purpose

The long-term vision includes a dependable offline knowledge layer for emergencies and humanitarian settings. Kinetics should preserve access to verified scientific and health references during conflict, displacement, disasters, epidemics, remote-area emergencies and prolonged infrastructure failure. This requires signed and versioned local knowledge packs, offline search, low-power operation, removable-media distribution, printable references, integrity verification, privacy protections and tested recovery. Emergency protocols must be curated and reviewed by qualified professionals for their intended jurisdiction and user role. Kinetics must never claim flawless operation or replace emergency services, trained responders or hands-on care. See [docs/EMERGENCY_HUMANITARIAN_RESILIENCE.md](docs/EMERGENCY_HUMANITARIAN_RESILIENCE.md).

## The larger horizon

Kinetics should be designed as an evolving public-benefit scientific infrastructure: extensible across disciplines, interoperable across institutions, usable across device classes and resilient across infrastructure conditions. Its future may include federated research, privacy-preserving computation, portable scientific libraries, collaborative evidence curation, validated multimodal analysis and new scientific domains not yet anticipated. These are strategic directions, not claims of current capability. Each must earn its place through lawful data access, scientific rationale, engineering feasibility, independent evaluation and measurable benefit.

The ambition is to help humanity build a deeper, more connected understanding of life and disease; make research more reproducible and accessible; and preserve essential knowledge for future generations. The measure of success is not maximal feature count, but trustworthy scientific utility and responsible contribution to human health.
